Compounds > 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline
Page last updated: 2024-09-03

8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline and Infections, Plasmodium

8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline has been researched along with Infections, Plasmodium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashley, EA; Charunwatthana, P; Day, NP; Hanboonkunupakarn, B; Hanpithakpong, W; Jittamala, P; Lawpoolsri, S; Lee, SJ; Pukrittayakamee, S; Tarning, J; White, NJ1
Baresel, PC; Campo, B; Marcsisin, SR; Reichard, GA; Rochford, R; Sousa, J; Tekwani, BL; Vuong, CT; Walker, LA; Wickham, KS1

Trials

1 trial(s) available for 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline and Infections, Plasmodium

ArticleYear
Pharmacokinetic interactions between primaquine and chloroquine.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Adult; Antimalarials; Chloroquine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Young Adult

2014

Other Studies

1 other study(ies) available for 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline and Infections, Plasmodium

ArticleYear
Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Animals; Antimalarials; Disease Models, Animal; Erythrocyte Transfusion; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria; Mice, SCID; Primaquine

2016